HEART Pathway
Chest pain. Risk-stratified.
免費
1.6.1for iPhone, iPod touch
Age Rating
HEART Pathway 螢幕截圖
About HEART Pathway
A validated clinical decision tool for patients presenting to the emergency department with chest pain, created by Wake Forest University School of Medicine physicians. For patients presenting with chest pain, the HEART Pathway algorithm has been shown to reduce patient length of stay by 12 hours, reduce cost by 14 percent per patient, and results in a MACE rate of < 1%.
If interested in licensing the HEART Pathway for use at your institution please contact us via our website.
HEART Pathway randomized controlled trial: http://www.ncbi.nlm.nih.gov/pubmed/25737484
Chest pain is a top cause of US ED visits. Eight to ten million patients with chest pain present to an ED annually in the United States. More than half of Emergency Department patients with chest pain receive lengthy cardiac evaluations in an chest pain unit or inpatient ward, with an annual cost $10-13 billion. Less than ten percent of patients have an acute coronary syndrome (ACS). Two to five percent of patients with myocardial infarctions are inappropriately discharged from the ED every year. Missed ACS is a top cause of malpractice claims.
What is the HEART Pathway?
The HEART Pathway is designed for more accurate cardiac risk stratification for patients presenting to the ER with Chest Pain. The HEART Pathway is similar to the HEART Score but has been modified by researchers at Wake Forest University School of Medicine.
The HEART Pathway has been validated by researchers at Wake Forest University School of Medicine and is used on a daily basis at Wake Forest and our affiliate emergency departments.
The HEART Pathway randomized controlled trial (Mahler et al, Circ CVQO J, 2015.) has demonstrated the benefits of the HEART Pathway compared with usual care. When HEART Pathway was applied to chest pain patients researchers found an increase in early discharge rate from 18% to 39% with a cost savings of over $200 per patient.
The HEART Pathway assists providers with answering the following questions:
Should I admit my patient for stress testing or can I discharge my patient from the Emergency Room?
What is the likelihood that my patient’s presenting symptoms represent ACS?
What is the likelihood that my patient will have an ACS event in the near future (within 30 days)?
If interested in licensing the HEART Pathway for use at your institution please contact us via our website.
HEART Pathway randomized controlled trial: http://www.ncbi.nlm.nih.gov/pubmed/25737484
Chest pain is a top cause of US ED visits. Eight to ten million patients with chest pain present to an ED annually in the United States. More than half of Emergency Department patients with chest pain receive lengthy cardiac evaluations in an chest pain unit or inpatient ward, with an annual cost $10-13 billion. Less than ten percent of patients have an acute coronary syndrome (ACS). Two to five percent of patients with myocardial infarctions are inappropriately discharged from the ED every year. Missed ACS is a top cause of malpractice claims.
What is the HEART Pathway?
The HEART Pathway is designed for more accurate cardiac risk stratification for patients presenting to the ER with Chest Pain. The HEART Pathway is similar to the HEART Score but has been modified by researchers at Wake Forest University School of Medicine.
The HEART Pathway has been validated by researchers at Wake Forest University School of Medicine and is used on a daily basis at Wake Forest and our affiliate emergency departments.
The HEART Pathway randomized controlled trial (Mahler et al, Circ CVQO J, 2015.) has demonstrated the benefits of the HEART Pathway compared with usual care. When HEART Pathway was applied to chest pain patients researchers found an increase in early discharge rate from 18% to 39% with a cost savings of over $200 per patient.
The HEART Pathway assists providers with answering the following questions:
Should I admit my patient for stress testing or can I discharge my patient from the Emergency Room?
What is the likelihood that my patient’s presenting symptoms represent ACS?
What is the likelihood that my patient will have an ACS event in the near future (within 30 days)?
Show More
最新版本1.6.1更新日誌
Last updated on 2019年04月06日
歷史版本
- Bug Fixes
Show More
Version History
1.6.1
2019年04月06日
- Bug Fixes
1.6.0
2019年04月01日
- You can now save a list of previous scores that you have calculated
- New App Icon
- New App Icon
1.5.7
2018年05月20日
- Fixed bug affecting some users that caused a crash before results could be viewed.
1.5.6
2018年05月17日
Updated contact information.
1.5.2
2016年09月06日
Minor UI updates.
1.5.1
2016年07月15日
Minor UI updates.
Licensing information updates.
Licensing information updates.
1.1.1
2016年05月06日
-Minor UI updates
-Health system licensing information
-Health system licensing information
1.0.8
2016年04月18日
-Updated graphics
-Improved iOS version support
-Improved iOS version support
1.0.1
2016年04月12日
- Visual refinements to the user interface
- Additional educational content
- Enhancement of results display
- Additional educational content
- Enhancement of results display
1.0
2016年03月31日
HEART Pathway FAQ
點擊此處瞭解如何在受限國家或地區下載HEART Pathway。
以下為HEART Pathway的最低配置要求。
iPhone
須使用 iOS 10.0 或以上版本。
iPod touch
須使用 iOS 10.0 或以上版本。
HEART Pathway支持英文